Past Events

Nov

19

2024

Nov

04

2024

Verona Pharma Third Quarter 2024 Financial Results and Conference Call

Aug

13

2024

44th Annual Canaccord Growth Conference

Aug

08

2024

Verona Pharma Second Quarter 2024 Financial Results and Conference Call

Jun

27

2024

Verona Pharma OhtuvayreTM FDA Approval Conference Call and Webcast

Developing novel therapeutics for respiratory diseases

Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.